Glioblastoma treatment with the anticancer drug epidermal growth factor receptor‐targeted diphtheria toxin (DT‐ EGF) induces autophagy and HMGB1 release from tumor cells, and HMGB1 release is greatly reduced with autophagy inhibition. The gene discussed is HMGB1; the disease is glioblastoma.